Prescription Drug Daytrana Patches Recalled for Defective Delivery System
Noven Pharmaceuticals is recalling Daytrana methylphenidate transdermal patches from Lot 90764 (expiration 08/2022) distributed nationwide due to defects in the delivery system. The recall was initiated after customer complaints exceeded FDA action limits.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This recall involves a prescription drug with a defective delivery system that poses a risk of improper medication delivery. No illnesses or injuries are reported, which limits the score to 3 per the rubric. FDA Class II classification without hospitalization reports confirms this severity level.
Plain-English summary
Noven Pharmaceuticals Inc is recalling Daytrana (methylphenidate) transdermal patches from Lot 90764 (expiration 08/2022) that were distributed nationwide. The recall was issued due to defects in the patch delivery system.
Customer complaints regarding the delivery system defect exceeded the FDA's action limits, triggering the recall. The specific nature of the defects is not detailed in the recall notice, nor are any adverse health events reported.
Patients who received Daytrana patches from the affected lot should consult their healthcare provider. Healthcare providers and patients should not use patches from the affected lot.
The recalled product
- Product
- DAYTRANA (METHYLPHENIDATE)
- Brand
- DAYTRANA
- Manufacturer
- Noven Pharmaceuticals Inc
- Category
- Drug — Transdermal Patch
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot: 90764 Exp. 08/2022
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · DAYTRANA
- HighDaytrana methylphenidate patches recalled for defective delivery system
FDA (Drugs) · 2023-03-29
- ModerateDaytrana Methylphenidate Patches Recalled for Defective Delivery System
FDA (Drugs) · 2023-03-29
- HighDaytrana Methylphenidate Transdermal Patches Recalled for Defective Delivery System
FDA (Drugs) · 2023-03-29
- HighDaytrana Methylphenidate Patches Recalled for Defective Transdermal Delivery System
FDA (Drugs) · 2023-03-29
- HighDaytrana transdermal methylphenidate patches recalled for adhesive defect
FDA (Drugs) · 2022-12-07
Same manufacturer · Noven Pharmaceuticals Inc
See all →- HighPrescription Dextroamphetamine Patches Recalled for Defective Adhesive System
FDA (Drugs) · 2024-11-27
- HighMethylphenidate Patch Recall: Defective Delivery System and Adhesive Issues
FDA (Drugs) · 2022-07-06
Same hazard · delivery system defect
See all →- ModerateSimethicone Oral Syringe Recalled for Defective Delivery System
FDA (Drugs) · 2025-03-12
- HighMorphine Sulfate Oral Syringes Recalled for Defective Delivery System Leakage
FDA (Drugs) · 2025-03-12
- ModerateVitamin D Supplement Oral Syringes Recalled for Defective Delivery System
FDA (Drugs) · 2025-03-12
- SevereFentanyl Transdermal Patches Recalled for Defective Delivery System
FDA (Drugs) · 2025-02-26
- ModerateRyaltris Nasal Spray Recalled for Clogged Dip Tube
FDA (Drugs) · 2024-10-09